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INTRODUCTION
Chronic pulmonary disease in horses is mostly due
to allergic bronchiolitis. In a minority of cases other ty-
pes of underlying pathologies such as mycotic granu-
lomas, lipoid pneumonia, bacterial abscesses, silicate
pneumoconiosis or neoplasia are found. In many cases,
however, the etiology remains unknown (Buergelt et al.,
1986). Recently in the US, equine multinodular pul-
monary fibrosis (EMPF) has been reported as a new form
of chronic pulmonary disease (Williams et al., 2007). 
EMPF is a fibrotic lung disease suspected to be as-
sociated with EHV 5 infection. The clinical signs include
weight loss, anorexia, fever, lethargy and respiratory pro-
blems. Diagnosis is made post-mortem by necropsy and
histopathology. An ante-mortem suspicion of EMPF can
be based on clinical symptoms, radiographs, biopsy and
PCR for EHV 5 on bronchoalveolar lavage fluid. 
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ABSTRACT
A 20-year-old horse was evaluated for symptoms of weight loss, anorexia, fever and lethargy. Clinical
examination revealed tachypnea, poor body condition and increased breath sounds on auscultation.
Ultrasound showed multiple consolidations on the lungs. Thoracic radiography revealed a severe nodular
pattern. The horse was treated with antibiotics, corticoids and supportive medication. Since no improvement
was observed, the horse was euthanized.
At necropsy, numerous coalescing fibrous nodules were present in the lungs. Histology revealed diffuse
interstitial fibrosis and macrophages containing abundant eosinophilic cytoplasm and oval eosinophilic to
amphophilic intranuclear inclusion bodies. Tissue samples tested positive for the presence of equine herpes
virus 5 (EHV 5) on the basis of the polymerase chain reaction (PCR) test. A diagnosis of equine multinodular
pulmonary fibrosis (EMPF) was made. This is the first report of EMPF in Belgium. EMPF can be suspected
based on the ultrasonographic, radiographic and histological changes. EMPF is associated with EHV 5, but
the etiological role of EHV 5 still remains to be proven. 
SAMENVATTING
Een twintig jaar oude merrie werd aangeboden met anorexie, gewichtsverlies, koorts en sufheid. Tijdens het
klinisch onderzoek werden een slechte lichaamsconditie, een verhoogde ademhalingsfrequentie en versterkte
ademhalingsgeluiden aangetoond. Op het echografisch onderzoek waren meerdere verdichtingen in de long zichtbaar,
hetgeen bevestigd werd door de radiografische bevindingen. Het paard werd behandeld met antibiotica en steroïden
en kreeg een ondersteunende therapie, maar door het gebrek aan verbetering werd uiteindelijk beslist om het dier te
euthanaseren. Op de lijkschouwing werden meerdere coalescerende nodulen in de longen aangetroffen. Histologie
van de nodulen wees op een diffuse interstitiële fibrose met macrofagen die een sterk eosinofiel cytoplasma hadden,
met de aanwezigheid van ovale eosinofiele tot amfofiele intranucleaire inclusies. Equine Herpesvirus (EHV) type 5
werd met PCR aangetoond in het weefsel van het paard. De diagnose van equine multinodulaire pulmonaire fibrose
(EMPF) werd gesteld. 
Dit is het eerste rapport van EMPF in België. EMPF kan gediagnosticeerd worden aan de hand van de
echografische, radiografische en lijkschouwingsbevindingen. EHV5 lijkt gecorreleerd te zijn met EMPF, maar verder
onderzoek is nodig.
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A 20-year-old French warmblood mare, born and rai-
sed in Belgium, was presented to the Faculty of Vete-
rinary Medicine at Ghent University with symptoms of
weight loss, anorexia, fever and lethargy during the
preceding 2-3 weeks. Prior to presentation at the clinic,
blood analysis had revealed anemia and hypopro -
teinemia. The horse had been treated with antibiotics
(cefquinome) and steroids (dexamethasone). This treat-
ment reduced the fever, but the horse remained lethar-
gic. On one occasion, the horse had shown signs of dif-
ficulty breathing and a trace of blood at the nostrils was
seen by the owner.
The horse had been vaccinated on a yearly basis
against influenza and tetanus, but not against EHV. The
mare had no history of significant previous illnesses, had
not participated in any competitions, and had lived in
a private stable with three other horses.
Clinical findings
At the moment of presentation, clinical examina tion
of the horse was unremarkable except for a slight in-
 crease in respiration rate (28/min) and poor body con-
dition (weight 454kg).
Auscultation of the lungs at rest revealed increased
breath sounds on both sides. An ultrasound of the lungs
was performed and showed multiple consolidations on
the left and right side of the lung surface (1-3cm dia-
meter). No increased amount of pleural fluid was seen. 
A complete blood analysis showed slight anemia
(PCV 28%, reference range (rr) 35-45%) and marked
hypoproteinemia (protein concentration 45 g/l, rr 60-
80 g/l), comparable to the results of the previous blood
analysis. Other blood values were within normal limits.
Arterial blood gas analysis revealed a severe hypo -
xemia (PaO2: 69.3 mmHg, rr 95-105 mmHg) and nor-
mocapnea.
On endoscopy of the upper airways, petechial
bleedings were seen in the pharynx and an increased
amount of mucus was present in the trachea. Analysis
of this mucus revealed a low nucleated cell count con-
sisting predominantly of macrophages. Overnight aero-
bic culture of this mucus was bacteriologically nega-
tive. Bacteriological examination of bronchoalveolar
lavage (BAL) fluid was negative and the cytology was
moderately cellular, with the presence of mucus
strands. The intact cells were mostly vacuolated ma-
crophages with large nuclei and multiple prominent nu-
cleoli. Some macrophages were multinucleated. Fewer
segmented neutrophils were present. No inclusion bo-
dies were found.
Thoracic radiography revealed a severe diffuse
cloudy increase in opacity of mainly the dorsal and dor-
socaudal lung field, obscuring the vasculature and the
bronchial walls. Several ovoid rims of soft tissue opa-
city were visible throughout the dorsal lung field.
Differential Diagnosis
Based on the clinical signs and the ultrasonographic
and radiographic lesions, the differential diagnosis in-
cluded neoplasia, idiopathic granulomatous pneumonia,
bacterial, fungal or parasitic pneumonia, and the recently
described equine multinodular pulmonary fibrosis
(Williams et al., 2007; Wong et al., 2008). The ab sence
of inflammatory changes in the respiratory secretions
and the negative bacteriological cultures made neoplasia,
idiopathic granulomatous pneumonia or equine multi-
nodular pulmonary fibrosis more likely.
Biopsy
A lung biopsy was performed under ultrasonogra-
phic guidance with a TruCut biopsy needle (Cook ® 16G
20mmT 15cm) at the 6th intercostal space after seda tion
with 0.2ml of detomidine (Detogesic, Fort Dodge, Muur-
la, Finnland) and local anesthesia with 1ml of pro caine
(Procaïnehydrochloride 4% + adrenaline, Kela nv,
Hoogstraten, Belgium). 
Histological examination revealed a diffuse severe
interstitial fibrosis with infiltration of macrophages and
neutrophils. There was marked hyperplasia of the type
II pneumocytes and some alveolar lumina contained exu-
date with mainly degenerated neutrophils. A diagnosis
of diffuse severe interstitial pneumonia was made ba-
sed on the histological lesions. 
Treatment and clinical course
A treatment with antibiotics and corticosteroids was
started. For a period of 10 days, cefquinome (cobactan
1mg/kg, Intervet, Mechelen, Belgium) was given intra -
muscularly SID in combination with 2000 mg predni-
solon orally SID during the first 2 days. Thereafter the
dosage of prednisolone was lowered to 1000mg SID du-
ring the next 8 days. Additionally, ipratropium bro mide
(Atrovent (R) 400mcg, Boehringer Ingelheim, Great-
Britain) was given by aerosol TID and acetylcysteine
(Lysomucil, Zambon, Brussels, Belgium) 600mg BID
was administered orally for 5 days.
During the treatment, intermittent fever was noted,
with temperatures fluctuating between 37.6°C and
39.2 °C. 
Five days after the start of the treatment, blood gas
analysis showed a normal PaO2 (98.3 mmHg). How ever,
from the 6th day of treatment on, the horse also deve-
loped intermittent bouts of mild colic, with reduced fe-
cal passage and mild cecal tympany. Throughout the
treatment period, the horse remained anorexic and con-
tinued to lose weight.
Ten days after admission, a control x-ray was taken
and showed no improvement. 
Given the age of the horse, the deterioration of its
general condition and the lack of radiographic impro-
vement, the owners decided to have the horse euthanized.
A complete necropsy was performed.
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Necropsy and histopathology
The liver was moderately enlarged, with random foci
of calcification (diameter 1-2mm). Several left para-ova-
rian cysts were present and severe ulcerative gastritis
was found. The most severe changes, however, were pre-
sent in the lungs. All the lung lobes were affected. The
dorsocaudal lung lobes showed the most prominent le-
sions, as numerous coalescing fibrous nodules were pre-
sent. These nodules were moderately firm and white.
The ventral lung regions showed multifocal nodules with
a similar appearance, though smaller in size. The dia-
meter of the individual nodules throughout the lung pa-
renchyma ranged from 1 to 7cm. Approximately 80%
of the lung tissue was affected. On cut surface, the fi-
brous nodules bulged slightly from the surrounding tis-
sue. Furthermore, the retropharyngeal and bronchial
lymph nodes were markedly enlarged. The larynx and
trachea showed no abnormalities. 
Impression smears of lung tissue were moderately
cellular. Intact cells were mostly vacuolated macro-
phages, some multinucleated. Few neutrophils were pre-
sent. In these impression smears, no inclusion bodies
were detected and bacteria or other infectious agents
were not observed.
Representative tissue samples of the lungs were fixed
in phosphate buffered formalin. After fixation, the sam-
ples were routinely embedded in paraffin wax, cut in
5-µm-thick sections and stained with standard hema-
toxylin and eosin (HE) and Elastica von Gieson.
Several sections were incubated with a polyclonal
rabbit anti-human CD3(Dakocytomation, Glostrup, Den-
mark) that labels T-lymphocytes (both helper and
cyto toxic T-lymphocytes), a monoclonal mouse anti-hu-
man CD79 (clone HM57, Dakocytomation) that labels
B-lymphocytes, a monoclonal mouse anti-human HLA-
DRa (clone TAL-1B5, Dakocytomation) that labels
MHC II positive cells, and a monoclonal mouse anti-
body anti-MAC387 (Abcam, Cambridge, UK) that la-
bels reactive and tissue macrophages. Significant
histologic lesions were restricted to the lungs. The no-
dules were more or less sharply demarcated from ad-
jacent less affected lung parenchyma. The lesions
consisted of diffuse intense interstitial fibrosis with in-
terstitial infiltration of a moderate amount of CD3 po-
sitive cells (T-lymphocytes). The alveolar lumina were
diffusely lined with cuboidal cells (proliferation of type
II pneumocytes) and contained large numbers of va-
cuolated macrophages (confirmed by MAC 387 staining)
and fewer neutrophils. A small number of macropha-
ges contained abundant eosinophilic cytoplasm and a
large oval eosinophilic to amphophilic intranuclear in-
clusion body (Figure 1). The bronchi showed no ab-
normalities.
Virological examination
The presence of intranuclear inclusion bodies could
possibly indicate sites for the presence of viruses such
as herpesviruses, so lung tissue was submitted for viral
isolation and/or polymerase chain reaction (PCR) as-
says. Virus isolation was performed as previously
described (van der Meulen et al.; 2003). Briefly, 20%
suspensions of lung tissue were titrated on equine em-
bryonic kidney (EEK) cells and the wells were inspected
daily for the presence of cytopathic effects. No plaque
formation was observed after 7 days of incubation, and
therefore the sample was considered negative for EHV
1 and EHV 4. The presence of EHV 1 virus was further
investigated by immunohistochemical staining on
fixed lung tissue samples. Sections of lung were im-
munolabeled for EHV 1 antigen with a polyclonal goat
antibody against EHV 1 (VHRD, Pullman, Washington,
USA) and a commercial kit (Dakocytomation Envision
System HRP). Immuno histo chemical staining for EHV
1 was negative.
To detect the presence of EHV 2 or EHV 5 genome
copies, DNA was extracted from the lung tissue and am-
plified by PCR, exactly as described elsewhere (Bor-
chers et al., 1999). The lung tissue was negative for EHV
2, but was positive for EHV 5.
DISCUSSION
In this study, we describe the second case of her-
pesvirus-associated multinodular pulmonary fibrosis in
a horse found outside of North America.
In 2007 Williams et al. described the first cases of
equine multinodular pulmonary fibrosis (EMPF) in
horses. Since then, only two additional reports of
multinodular pulmonary fibrosis have been published
(Wong et al., 2008, Hart et al., 2008), including one horse
from the Newmarket area in England (Wong et al.,
2008). 
On the basis of the gross pathology, we can discern
two manifestations of EMPF. The first shows numerous
coalescing nodules of fibrosis 1-5cm in diameter. The
nodules are pale white and moderately firm. A large por-
tion of the lung is affected. The horse in this case re-
port showed the typical lesions of the first manifesta-
tion. The second type of manifestation occurs less fre-
Figure 1. Lung of the mare. Alveolar macrophage with in-
tranuclear presence of herpesvirus inclusion body. HE,
1000x.
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quently and is characterized by multiple discrete nodules
10cm in diameter. Grossly unaffected lung is present
(Williams et al., 2007). 
The histology in both types shows diffuse intersti-
tial fibrosis and alveolar lumina lined by cuboidal cells
and filled with several vacuolated macrophages. Some
of the macrophages contain large eosinophilic intra-
nuclear inclusion bodies indicative for herpesviruses
(Williams et al., 2007; Wong et al., 2008; Hart et al.,
2008). The average age of the affected horses was 14.5
years (Williams et al., 2007; Wong et al., 2008), with
ages ranging from 4 to 26 years (Williams et al., 2007).
The horse in the present case was 20 years old and pre-
sented all the typical gross and histologic lesions as des-
cribed in the previous articles. 
EMPF is reported to be associated with EHV 5 (Wil-
liams et al., 2007; Hart et al., 2008; Wong et al., 2008).
The present case tested positive for EHV 5. 
The etiology and pathogenesis of EMPF and, by ex-
tension, the role of EHV 5 in this syndrome remain un-
clear. In all cases of EMPF described so far, EHV 5 is
present, but causality has not yet been proven. 
EHV 5 has been detected in healthy horses in dif-
ferent parts of the world. Fortier et al. (2008) demon-
strated the presence of EHV5 by PCR in 19 out of 785
bronchoalveolar and tracheal lavages of French horses.
In New Zealand, 38 out of 114 healthy horses tested po-
sitive with PCR for EHV 5 (Dunowska, Meer and Wilks,
1999). In Hungary, 15% of the foals tested were posi-
tive for EHV 5 by PCR on peripheral blood leucocy-
tes, and in the United Kingdom 24% of a group of 21
ponies tested positive (Nordengrahn et al., 2002). In the
US the prevalence of EHV 5 in a group of young race
horses was estimated at 64% after a type-specific PCR
was used on nasopharyngeal excretions (Bell et al.,
2006). EHV 5 has also been detected in Switzerland
(Franchini et al., 1997) and Germany (Borchers et al.,
1999), but the prevalence numbers are not available. For
Belgium, no epidemiological data on the incidence of
EHV 5 infections in horses are available.
In some of the reported cases of EMPF, the presence
of EHV 2 has been demonstrated by PCR (Hart et al.,
2008; Williams et al., 2007). In our case, EHV 2 was
not detected. The inconsistent demonstration of EHV
2 probably only reflects the frequent co-infection of
horses by EHV 5 and EHV 2 (Torfasen et al., 2008).
The prevalence reports show that EHV 5 can be pre-
sent in a high number of horses in some countries (e.g.
US, Iceland) or in some horse populations. The reason
for the difference in prevalence numbers between
countries is not completely clear: perhaps different ma-
nagement techniques could have an influence on the pre-
valence. 
Given the relatively high prevalence of EHV 5 and
the few clinical cases of EMPF, the causality of EHV
5 in EMPF remains uncertain. Nevertheless there cer-
tainly are strong arguments in favor of a primary (or a
complicating) role of EHV 5 in the etiology of EMPF.
First of all, Williams et al. (2007) in their first description
of a series of cases detected EHV 5 by PCR in the le-
sions from all cases and not in the control horses. Se-
condly, EHV 5 has been amplified from all cases of
EMPF ever since (Wong et al., 2008; Hart et al., 2008),
including the present case.
Chronic proliferative interstitial lung diseases not as-
sociated with silicate pneumoconiosis or other known
etiologies were described as an idiopathic entity years
ago by Buergelt et al. (1986). In those cases, however,
the lesions did not present the typical multinodular pat-
tern which is so distinctive and characteristic of EMPF.
Also, in humans an idiopathic form of chronic pulmo-
nary fibrosis (IPF) is well known. Remarkably, in 97%
of human cases of IPF, herpesviral DNA is detected
(Tang et al., 2003).
The possible mechanism of fibrosis induction by her-
pesviridae is unknown. In mice, murine gamma -
herpesvirus 68 (MuHV4) has been shown to induce
fibrosis in the presence of a co-existing underlying fac-
tor such as bleomycin (Lok et al., 2002). Additionally,
it is known that humans with IPF have a T helper 2 (Th2)
pulmonary phenotype, characterized for example by the
presence of increased levels of the profibrotic cyto kine
transforming growth factor (TGF) b and Th2 cytokines,
which may ultimately lead to fibrosis and loss of lung
function (Wallace et al., 1995). Therefore another
hypo thesis could be that the cytokine modulatory pro-
perties of herpesviruses (Alcami, 2003; Nicolas, 2005)
might drive the pulmonary immune system towards a
Th2-biased immune response, and hence contribute to
the development of chronic pulmonary lung fibrosis. For
EHV 5-associated EMPF in horses, no predisposing fac-
tors or changes in immune response have been identi-
fied to date.
EMPF is a difficult clinical diagnosis. Based on the
clinical examination, radiography and ultrasound,
EMPF can be suspected (Wong et al., 2008; Hart et al.,
2008), but the definite diagnosis of EMPF can only be
made post-mortem by necropsy and subsequent histo-
logical and virological examination of lung tissue. De-
monstrating the presence of EHV 5 in a patient is rea-
dily done since PCR can be performed on nasal swabs
(Bell et al., 2006; Dunowska, Meers and Wilsk, 1999),
bronchoalveolar and tracheal lavage fluids (Wong et al.,
2008, Fortier et al., 2008) or blood mononuclear cells
(Bell et al., 2006; Dunowska, Meers and Wilks 1999).
But, since EHV 5 can be present in a high number of
healthy horses, the mere identification of EHV 5 in a
patient is not conclusive for the diagnosis of EMPF. 
Also, in this case there was a suspicion of EMPF
based on clinical symptoms in combination with the
radiographic and ultrasonographic findings. The lung
biopsy in this case did not yield sufficient information
for a definite ante-mortem diagnosis. A definite
diagnosis was made at necropsy and histology. 
This is the first case of EMPF associated with EHV
5 described in Belgium. Further research is necessary
to elucidate the pathogenesis of this puzzling disorder
and especially to identify the possible role of EHV 5 in
the development of lung fibrosis. 
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